Radiology and Imaging

Medicine & Life Sciences

1. Radiology 100%
2. Neoplasms 95%
3. Magnetic Resonance Imaging 90%
4. Radiosurgery 74%
5. Radiologists 62%
6. Tomography 51%
7. Heat Shock Transcription Factors 51%
8. Cone-Beam Computed Tomography 50%
9. Heat-Shock Response 49%
10. Indoleamine-Pyrrole 2,3,-Dioxygenase 48%
11. Therapeutics 43%
12. T-Lymphocytes 41%
13. Brain 39%
14. Schizophrenia 38%
15. Radiotherapy 38%
16. Diffusion Tensor Imaging 37%
17. Spine 36%
18. Lung 36%
19. Positron Emission Tomography Computed Tomography 36%
20. Artifacts 35%
21. Radiation 35%
22. Lung Neoplasms 34%
23. Child 33%
24. Guidelines 32%
25. Psychotic Disorders 31%
26. Wounds and Injuries 29%
27. Contrast Media 28%
28. Anatomy 28%
29. Manganese 27%
30. Sickle Cell Anemia 27%
31. Pediatrics 27%
32. Neoplasm Metastasis 26%
33. Genes 25%
34. Direction compound 25%
35. Stroke 24%
36. Thorax 24%
37. Myocardial Infarction 24%
38. Skull Base 23%
39. Positron-Emission Tomography 22%
40. Nuclear Medicine 22%
41. White Matter 21%
42. Overweight 21%
43. Kidney 21%
44. Physicians 21%
45. Intra-Abdominal Fat 20%
46. SEA 0400 20%
47. X-Rays 20%
48. Traumatic Brain Injury 20%
49. Adipose Tissue 19%
50. Single-Photon Emission-Computed Tomography 19%
51. Anisotropy 19%
52. Hemorrhage 18%
53. Pathology 18%
54. Virus Diseases 18%
55. Pelvis 18%
56. Liver 17%
57. Neck 17%
58. Delivery of Health Care 17%
59. Bone and Bones 17%
60. Exercise 17%
61. Gallbladder 17%
62. Social Media 17%
63. Photons 17%
64. Adiposity 17%
65. Molecular Chaperones 17%
66. Biopsy 17%
67. Differential Diagnosis 17%
68. Technology 16%
69. Spinal Cord 16%
70. Education 16%
71. Recurrence 16%
72. Fluorodeoxyglucose F18 16%
73. Non-Small Cell Lung Carcinoma 16%
74. Magnetic Resonance Spectroscopy 16%
75. Prostatic Neoplasms 16%
76. Water 16%
77. Regulatory T-Lymphocytes 15%
78. Software 15%
79. Frontal Sinus 15%
80. Adenocarcinoma 15%
81. Carcinoma 15%
82. Brain Edema 15%
83. Hepatocellular Carcinoma 15%
84. Head 15%
85. Infratemporal Fossa 15%
86. ferric oxide 14%
87. Imaging Phantoms 14%
88. Lymphoma 14%
89. Amobarbital 14%
90. Survival 14%
91. Pancreatitis 14%
92. Pain 14%
93. Energy Metabolism 14%
94. Internal Carotid Artery 14%
95. Infections 14%
96. Rhabdomyosarcoma 14%
97. Patient-Centered Care 14%
98. Costs and Cost Analysis 14%
99. Temporal Lobe Epilepsy 13%
100. Immunotherapy 13%